| Literature DB >> 26263512 |
Maren Bleckmann1, Markus H-Y Fritz2, Sabin Bhuju3, Michael Jarek3, Margitta Schürig1, Robert Geffers3, Vladimir Benes2, Hüseyin Besir2, Joop van den Heuvel1.
Abstract
The Baculoviral Expression Vector System (BEVS) is the most commonly used method for high expression of recombinant protein in insect cells. Nevertheless, expression of some target proteins--especially those entering the secretory pathway--provides a severe challenge for the baculovirus infected insect cells, due to the reorganisation of intracellular compounds upon viral infection. Therefore, alternative strategies for recombinant protein production in insect cells like transient plasmid-based expression or stable expression cell lines are becoming more popular. However, the major bottleneck of these systems is the lack of strong endogenous polymerase II dependent promoters, as the strong baculoviral p10 and polH promoters used in BEVS are only functional in presence of the viral transcription machinery during the late phase of infection. In this work we present a draft genome and a transcriptome analysis of Sf21 cells for the identification of the first known endogenous Spodoptera frugiperda promoters. Therefore, putative promoter sequences were identified and selected because of high mRNA level or in analogy to other strong promoters in other eukaryotic organism. The chosen endogenous Sf21 promoters were compared to early viral promoters for their efficiency to trigger eGFP expression using transient plasmid based transfection in a BioLector Microfermentation system. Furthermore, promoter activity was not only shown in Sf21 cells but also in Hi5 cells. The novel endogenous Sf21 promoters were ranked according to their activity and expand the small pool of available promoters for stable insect cell line development and transient plasmid expression in insect cells. The best promoter was used to improve plasmid based transient transfection in insect cells substantially.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26263512 PMCID: PMC4532503 DOI: 10.1371/journal.pone.0132898
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The Sf21 genome assembly at a glance.
Only scaffolds of minimal size 300 bp were considered. CEG hits were computed with CEGMA [26] everything else with QUAST [25].
|
| 51,304 |
|
| 133,811 |
|
| 466,773,710 |
|
| 3354.37 |
|
| 1,212,604 |
|
| 36.22 |
|
| 99.19 |
Used Oligos for cloning,restriction sites are shown in bold.
| Name | Sequence 3`-5` | Length [bp] |
|---|---|---|
| pRibo60S-for | TATA | 34 |
| pRibo60S-rev | TAAT | 44 |
| pRiboL34-for | ATTA | 43 |
| pRiboL34-rev | TAAT | 41 |
| pRiboS11-for | ATTA | 44 |
| pRiboS11-rev | ATTA | 42 |
| pRiboL23-for | ATTA | 40 |
| pRiboL23-rev | TAAT | 43 |
| pEF1ΔI-for | ATTA | 43 |
| pEF1ΔI-rev | TATA | 39 |
| pEF1-for | ATTA | 35 |
| pEF1-rev | TATA | 30 |
| pGAPDHΔI-for | ATTA | 47 |
| pGAPDHΔI-rev | TAAT | 35 |
| pGAPDH-for | ATTA | 40 |
| pGAPDH-rev | TAAT | 43 |
| pEnolaseΔI-for | ATTA | 45 |
| pEnolaseΔI-rev | TAAT | 38 |
| pEnolase-for | ATTA | 40 |
| pEnolase-rev | TAAT | 38 |
| pActin-for | ATTA | 40 |
| pActin-rev | TAAT | 42 |
| pPGK-for | ATTA | 39 |
| pPGK-rev | ATAT | 38 |
| pHsp70-for | ATTA | 35 |
| pHsp70-rev | TAAT | 36 |
| IntronGADH-for | ATTA | 32 |
| IntronEF1-for | ATTA | 28 |
Fig 1Schematic overview of the selected putative SF21 promoter regions.
Shown are the predicted length, transcription start site and possible introns in leader sequence. Hatched regions highlight identical sequences in constructs with and without an intron.
Putative Sf21 promoter regions: The upstream regions were either chosen because of high mRNA levels or high expression of corresponding genes in other eukaryotic systems.
| Group | Name | Protein | RSEM | Predicted Length |
|---|---|---|---|---|
| Highest transcript-level | pRibo60S | 60S Acidic ribosomal protein P1 | 7556 | 1130 bp |
| pRiboL34 | Ribosomal protein L34 | 6388 | 972 bp | |
| pRiboS11 | 40S Ribosomal protein S11 | 5218 | 908 bp | |
| pRiboL23 | Ribosomal protein L23A | 3376 | 1008 bp | |
|
| ||||
| Strong analogous promoters | pEF1ΔI | Elongation factor 1-α | 3076 | 1029 bp |
| pEF1 | Elongation factor 1-α | 3076 | 957 bp | |
| pGAPDHΔI | Glyceraldehyde-3-phosphate dehydrogenase | 396 | 989 bp | |
| pGAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 396 | 1844 bp | |
| pEnolaseΔI | Enolase | 1731 | 1020 bp | |
| pEnolase | Enolase | 1731 | 1002 bp | |
| pActin | Actin | 58 | 985 bp | |
| pPGK | Phosphoglycerate kinase | 35 | 934 bp | |
| pHsp70 | Heat shock protein 70 A1 | 19 | 1034 bp | |
|
| ||||
| Early viral promoters | hr5IE1p10 | Combination of enhancer hr5, early viral promoter IE1 and the very late promoter p10 (AcMNPV) | 1197 bp | |
| OpIE1 | Early viral promoter (OpMNPV) | 292 bp | ||
| OpIE2 | Early viral promoter (OpMNPV) | 553 bp | ||
|
| ||||
| Combination with OpIE2 | OpIE2-IntronEF1 | Viral protein + EF1-intron | 1191 bp | |
| OpIE2-IntronGADH | Viral protein +GADH-intron | 1981 bp | ||
Fig 2Cultivation and evaluation of eGFP expression using the BioLector system.
a) Cultivation in the BioLector showing stable temperature at 27°C, humidity at around 85%, growing cell density and increasing eGFP fluorescence for Hi5 cells transfected with the OpIE2-eGFP plasmid b) Correlation between cell density measured in BioLector and cell number measured in Guava c) Transfection efficiency measured in the Guava 52 h after transfection. A transfection efficiency of 20% was reached in this experiment.
Fig 3Promoter activity in Sf21 cells over time measured in the BioLector.
Only the baculoviral promoters OpIE2 (black) and hr5IE1p10 (brown) showed detectable eGFP expression.
Fig 4Measured activity of the endogenous Sf21 promoters in Hi5 cells in the BioLector.
(A) Comparison of all endogenous Sf21 promoters with high steady state transcript level. (B) Comparison of all endogenous Sf21 promoters with highly active analogues in other eukaryotic systems.
Fig 5Influence of the intron on the respective promoter as well as on the OpIE2 promoter in Hi5.
Deletions of the intron sequence for all three promoters led to a decrease in activity. Fusion of the GAPDH or the EF1 intron downstream to the OpIE2 promoter did not enhance the activity. On the contrary the fusion to GAPDH intron decreased eGFP expression completely.
Fig 6Maximum eGFP yield for all endogenous Sf21 promoters and early viral promoters in Hi5 cells.
Fig 7Comparison of transient plasmid based expression in Hi5 cells with the OpIE2 promoter and HEK293-6E cells with the CMV promoter.